1Anan F, Masaki T, Umeno Y, et al. Correlations between homocysteine levels and atherosclemsis in Japanese type 2 diabetic patients[J]. Metabolism, 2007,56(10) : 1390 - 1395.
3Akalin A, Alatas O, Colak O. Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients[J]. Eur J Endocrinol,2008,158( 1 ) :47 - 52.
5Sun Y, Lu C J, Chien KL, et al. Efficacy of multivitamin supplementation containing vitamins 136 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer' s disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwan Residents patients [J]. Clin Ther,2007,29(10) :2204 - 2214.
6Yelmanarayan R,Suryvanshi M,Singh M, et al. A comparative study of the glycemic control of various antidiabetic agents and the role of homocysteine in the therapy of type 2 diabetes mellitus[J]. J Diabetes Complications, 2008,22(2) : 104 - 111.
2McCann VJ,Stanton KG,Van Bockxmeer FM,et al.Plasma homocysteine and serum folate levels in diabetes.Diabetologia,1998,41 (suppl1):1143.
3Matthews DR,Hosker JP,Rudenski AS,et al.Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia,1985,28:412-419.
4Soinio M,Marnlemi J,Laakso M,et al.Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus.Ann Intern Med,2004,140:94-100.
5Dicker-Brown A,Fonseca VA,Fink LM,et al.The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-beta-synthase:studies in hepatocytes.Atherosclerosis,2001,158:297-301.
6Fonseca V,Guba SC,FinkLM.Hyperhomocysteinemia and the endocrine system:implications for atherosclerosis and thrombosis.Endocrine Rev,1999,20:738-759.
7Carlsen SM,Folling I,Grill V,et al.Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease.Scand J Clin Lab Invest,1997,57:521-527.
8Buysschaert M,Dramais AS,Wallemacq PE,et al.Hyperhomocysteinemia in type 2 diabetes:relationship to macroangiopathy,nephropathy,and insulin resistance.Diabetes Care,2000,23:1816-1822.
9Eikebcom JW,Lonn E,Genest JJ,et al.Homcoyst (e)ine and cardiovascular disease:a critical review of the epidemiologic evidence.Ann Intern Med,1999,131:363-375.
10Okada E,Oida K,Tada H,et al.Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in type 2 diabetes.Diabetes Care,1999,22:484-490.
5Akalin A, Alatas O, Colak O. Relation of plasma homocysteine levels to athero- sclerotic vascular disease and inflammation mark- ers in type 2 diabetic patients [J]. Eur J Endocrinol, 2008, 158 ( 1 ) : 47-52.
6Emoto M, Kanda H, Shoji T, et al. Impact of insulin resistant a,ld nephropathy on homocysteine in type 2 diabetes[J]. Diabetes Care, 2001, 24 (3): 533-538.
